The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice

European Journal of Pharmacology

Volumn 592, Issue 1-3, 2008, Pages 87-92

  Kiguchi, Norikazu ^a   Maeda, Takehiko ^a   Kobayashi, Yuka ^a   Kondo, Toshikazu ^a   Ozaki, Masanobu ^b   Kishioka, Shiroh ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Allodynia; Interleukin 6; Macrophage; Neuropathic pain; Sciatic nerve; Vincristine

Indexed keywords

INTERLEUKIN 6; NEUTRALIZING ANTIBODY; VINCRISTINE SULFATE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HINDLIMB; IMMUNOHISTOCHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCIATIC NERVE; WITHDRAWAL REFLEX;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; MICE, KNOCKOUT; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICAL STIMULATION; SCIATIC NERVE; VINCRISTINE;

EID: 49749142983     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.008     Document Type: Article

References (43)

1. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., MacIntyre D.E., and Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7947-7952
2. Aley K.O., Reichling D.B., and Levine J.D. Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience 73 (1996) 259-265
3. Arruda J.L., Sweitzer S., Rutkowski M.D., and DeLeo J.A. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res. 879 (2000) 216-225
4. Beyreuther B.K., Callizot N., Brot M.D., Feldman R., Bain S.C., and Stohr T. Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain. Eur. J. Pharmacol. 565 (2007) 98-104
5. Cho E.S., Lowndes H.E., and Goldstein B.D. Neurotoxicology of vincristine in the cat. Morphological study. Arch. Toxicol. 52 (1983) 83-90
6. Cui J.G., Holmin S., Mathiesen T., Meyerson B.A., and Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 88 (2000) 239-248
7. DeLeo J.A., Colburn R.W., Nichols M., and Malhotra A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 16 (1996) 695-700
8. Flatters S.J., and Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 109 (2004) 150-161
9. Ganapathi R., Hercbergs A., Grabowski D., and Ford J. Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin). Cancer Res. 53 (1993) 3262-3265
10. Himes R.H., Kersey R.N., Heller-Bettinger I., and Samson F.E. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res. 36 (1976) 3798-3802
11. Hu P., and McLachlan E.M. Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience 112 (2002) 23-38
12. Inoue K., Koizumi S., and Tsuda M. The role of nucleotides in the neuron-glia communication responsible for the brain functions. J. Neurochem. 102 (2007) 1447-1458
13. Kamei J., Nozaki C., and Saitoh A. Effect of mexiletine on vincristine-induced painful neuropathy in mice. Eur. J. Pharmacol. 536 (2006) 123-127
14. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., and Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368 (1994) 339-342
15. Lin Z.Q., Kondo T., Ishida Y., Takayasu T., and Mukaida N. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J. Leukoc. Biol. 73 (2003) 713-721
16. Lindenlaub T., Teuteberg P., Hartung T., and Sommer C. Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res. 866 (2000) 15-22
17. Liu T., van Rooijen N., and Tracey D.J. Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury. Pain 86 (2000) 25-32
18. Ma W., and Eisenach J.C. Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury. Neuroscience 121 (2003) 691-704
19. Ma W., and Quirion R. Up-regulation of interleukin-6 induced by prostaglandin E from invading macrophages following nerve injury: an in vivo and in vitro study. J. Neurochem. 93 (2005) 664-673
20. Ma W., and Quirion R. Increased calcitonin gene-related peptide in neuroma and invading macrophages is involved in the up-regulation of interleukin-6 and thermal hyperalgesia in a rat model of mononeuropathy. J. Neurochem. 98 (2006) 180-192
21. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 6 (2005) 521-532
22. Murphy P.G., Ramer M.S., Borthwick L., Gauldie J., Richardson P.M., and Bisby M.A. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur. J. Neurosci. 11 (1999) 2243-2253
23. Nozaki-Taguchi N., Chaplan S.R., Higuera E.S., Ajakwe R.C., and Yaksh T.L. Vincristine-induced allodynia in the rat. Pain 93 (2001) 69-76
24. Ogawa T., Mimura Y., Kato H., Ootsubo S., and Murakoshi M. The usefulness of rabbits as an animal model for the neuropathological assessment of neurotoxicity following the administration of vincristine. Neurotoxicology 21 (2000) 501-511
25. Okamoto K., Martin D.P., Schmelzer J.D., Mitsui Y., and Low P.A. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp. Neurol. 169 (2001) 386-391
26. Owellen R.J., Hartke C.A., Dickerson R.M., and Hains F.O. Inhibition of tubulin-microtubule polymerization by drugs of the vinca alkaloid class. Cancer Res. 36 (1976) 1499-1502
27. Polomano R.C., and Bennett G.J. Chemotherapy-evoked painful peripheral neuropathy. Pain Med. 2 (2001) 8-14
28. Quasthoff S., and Hartung H.P. Chemotherapy-induced peripheral neuropathy. J. Neurol. 249 (2002) 9-17
29. Ramer M.S., Murphy P.G., Richardson P.M., and Bisby M.A. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain 78 (1998) 115-121
30. Sandler S.G., Tobin W., and Henderson E.S. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology 19 (1969) 367-374
31. Scholz J., and Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 10 (2007) 1361-1368
32. Sommer C., Lindenlaub T., Teuteberg P., Schafers M., Hartung T., and Toyka K.V. Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res. 913 (2001) 86-89
33. Tanner K.D., Levine J.D., and Topp K.S. Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J. Comp. Neurol. 395 (1998) 481-492
34. Tanner K.D., Reichling D.B., and Levine J.D. Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat. J. Neurosci. 18 (1998) 6480-6491
35. Tofaris G.K., Patterson P.H., Jessen K.R., and Mirsky R. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J. Neurosci. 22 (2002) 6696-6703
36. Topp K.S., Tanner K.D., and Levine J.D. Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J. Comp. Neurol. 424 (2000) 563-576
37. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., and Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
38. Ueda H. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol. Ther. 109 (2006) 57-77
39. White F.A., Bhangoo S.K., and Miller R.J. Chemokines: integrators of pain and inflammation. Nat. Rev. Drug Discov. 4 (2005) 834-844
40. White F.A., Sun J., Waters S.M., Ma C., Ren D., Ripsch M., Steflik J., Cortright D.N., Lamotte R.H., and Miller R.J. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14092-14097
41. Xiao W., Boroujerdi A., Bennett G.J., and Luo Z.D. Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 144 (2007) 714-720
42. Xu X.J., Hao J.X., Andell-Jonsson S., Poli V., Bartfai T., and Wiesenfeld-Hallin Z. Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine 9 (1997) 1028-1033
43. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110